HealthTech Funding Made Easy: Commission-Free SEIS & EIS Investment with Oriel IPO

A HealthTech Funding Revolution: Commission-Free Angel Network Awaits You

Raising capital for a health tech startup often feels like running a marathon on uphill terrain. You’ve got innovative ideas, clinical know-how, but you hit roadblocks when it comes to funding. Traditional angel syndicates usually charge hefty commissions or carry hidden fees. Enter the commission-free angel network powered by Oriel IPO. It streamlines SEIS and EIS investment, cuts out middlemen, and puts you straight in front of genuine angel investors.

Oriel IPO isn’t just another platform. It’s your partner in growth, offering curated, tax-efficient deals and expert insights all in one place. No more nostalgia for fee-heavy crowdfunding sites. This is all about clarity, speed, and keeping more of your hard-earned funds. Ready to see how a commission-free angel network can transform your health tech journey? Revolutionizing Investment Opportunities in the UK with our commission-free angel network

Why SEIS and EIS Are a Game Changer for HealthTech Startups

When you’re building software for clinical workflows or designing a cutting-edge MedTech device, every pound counts. The UK’s Seed Enterprise Investment Scheme (SEIS) and Enterprise Investment Scheme (EIS) offer up to 50% and 30% income tax relief respectively. That’s like finding a hidden stash of cash when you need it most.

  • SEIS: Tax relief on investments up to £100,000 per tax year.
  • EIS: Relief on investments up to £1 million, plus Capital Gains Tax exemptions.
  • Carry-back & loss relief: Offset risks and protect your personal finances.

These incentives make early-stage investment more attractive for angels, especially in specialised sectors like HealthTech. But navigating eligibility, paperwork, and compliance can be daunting without a streamlined process.

Traditional Angel Syndicates vs Commission-Free Angel Network

Pulse Angels and Other Specialist Syndicates

Pulse Angels is a great example of a sector-focused group. They:

  • Invest between £50k–£500k in HealthTech and MedTech startups.
  • Provide mentorship from clinicians, founders, and operators.
  • Vet 200+ deals annually through rigorous due diligence.

No question, relying on domain experts provides comfort. You get quality deal flow and deep guidance. Many founders find value in that collective wisdom.

The Hidden Costs and Constraints

Here’s the catch with most syndicates:

  • Commission fees can chip away at raised capital.
  • Regulatory complexity if the platform isn’t FCA-regulated.
  • Limited transparency around subscription or admin charges.
  • Inconsistent deal sizes—some rounds close before you pitch.

Even with top-tier guidance, you might still lose out on a chunk of your funding to platform fees. If you’re scaling quickly or want multiple rounds, those costs add up.

How Oriel IPO Outshines Traditional Networks

Oriel IPO addresses these limitations with a commission-free angel network approach:

  1. Commission-Free Model
    No percentage cut on the funds you raise. Startups pay a transparent subscription fee instead.

  2. Curated SEIS/EIS Opportunities
    Every company on the platform meets strict eligibility criteria, so investors trust the quality.

  3. Educational Tools & Resources
    Step-by-step guides, webinars, and insights demystify SEIS and EIS for founders and angels alike.

  4. Seamless Digital Experience
    A centralised portal for pitch decks, term sheets, KYC, legal docs, and investor updates.

This means more capital heads to your R&D, hiring, or go-to-market activities. You still get expert feedback – but you keep a higher share of the funds. And your backers benefit from lower fees and tax relief, making them more likely to re-invest.

Streamlining Your Investment Journey

Here’s how a commission-free angel network with Oriel IPO works, in four simple steps:

  1. Create Your Profile
    Showcase your team, product roadmap, market traction, and financial projections.

  2. Submit for SEIS/EIS Vetting
    Oriel IPO reviews eligibility and confirms you meet the HMRC criteria.

  3. Engage Investors
    Connect with angels who specialise in health tech. Pitch, negotiate terms, and finalise the structure.

  4. Complete Funding Round
    Legal documents, KYC, digital signatures – all in one place. No hidden fees or surprise deductions.

By contrast, traditional syndicates often require manual coordination of each step. You spend days toggling between spreadsheets, email threads, and third-party legal advisors. Oriel IPO brings everything under one roof.

Halfway through your funding journey, you’ll realise the difference. Imagine closing a £250,000 SEIS round without a single commission fee. Picture applying those savings directly to your next clinical study. That’s what happens with a commission-free angel network.

Discover how our commission-free angel network simplifies SEIS & EIS funding

Getting Started with Oriel IPO’s Commission-Free Angel Network

Ready to dive in? Here’s a quick checklist:

  • Gather your pitch deck, team bios, and financial model.
  • Review the SEIS/EIS eligibility guide on Oriel IPO.
  • Budget for a straightforward subscription fee (no surprises).
  • Identify target investors within the platform’s HealthTech sector.

Pro tip: Attend an Oriel IPO webinar to see live demos and ask questions. You’ll get clarity on timelines and best practices. Plus, you’ll connect with a small group of peers who are raising at the same time.

Real Results from Early Adopters

Generated testimonials based on Oriel IPO’s value proposition:

“Using Oriel IPO felt like having a backstage pass to angel investors in HealthTech. I raised £150,000 under SEIS without losing a penny to commissions. Their step-by-step guides kept me on track.”
— Sarah Thompson, Founder of MediSync

“I’ve used equity crowdfunding before, but those platforms took up to 8% in fees. With Oriel IPO’s commission-free angel network, we retained more capital for R&D. The portal’s simplicity is unmatched.”
— Dr Kevin Li, CTO at BioPulse Therapeutics

“Oriel IPO made SEIS and EIS funding approachable. My co-founders and I felt supported by real experts, not just algorithms. We closed our pre-seed within weeks, commission free.”
— Priya Patel, CEO of HealthLink AI

Conclusion and Next Steps

Building the next big thing in health tech deserves more than just capital. You need a partner that values transparency, tax-efficiency, and sector expertise. Oriel IPO’s commission-free angel network delivers all three in one streamlined platform. No commission fees, curated SEIS/EIS deals, educational support, and a seamless digital experience.

Your innovation could change patient outcomes. Don’t let hidden fees slow you down. Take the first step toward a smoother, more profitable funding journey today.

Revolutionizing Investment Opportunities in the UK with our commission-free angel network

more from this section